Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-11-084896
Filing Date
2011-03-31
Accepted
2011-03-31 16:24:00
Documents
10
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1350969
2 SUBSIDIARIES OF REGISTRANT dex211.htm EX-21.1 648
3 CONSENT OF ERNST & YOUNG LLP dex232.htm EX-23.2 1549
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER OF THE COMPANY PURSUANT TO SECTION 302 dex311.htm EX-31.1 7947
5 CERTIFICATION OF PRESIDENT OF THE COMPANY PURSUANT TO SECTION 302 dex312.htm EX-31.2 7917
6 CERTIFICATION OF CEO OF THE COMPANY PURSUANT TO SECTION 906 dex321.htm EX-32.1 5198
7 GRAPHIC g167683tx_pg010a.jpg GRAPHIC 40313
8 GRAPHIC g167683tx_pg010b.jpg GRAPHIC 41916
9 GRAPHIC g167683tx_pg012.jpg GRAPHIC 47309
10 GRAPHIC g167683tx_pg053.jpg GRAPHIC 30902
  Complete submission text file 0001193125-11-084896.txt   1597009
Mailing Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807
Business Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807 (908) 704-1300
Aegerion Pharmaceuticals, Inc. (Filer) CIK: 0001338042 (see all company filings)

EIN.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34921 | Film No.: 11726530
SIC: 2834 Pharmaceutical Preparations